- Home
- HURA vs SANG Comparison
HURA vs SANG Comparison
Compare HURA & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HURA | SANG |
|---|---|---|
| Founded | 2009 | 1984 |
| Country | United States | Canada |
| Employees | 22 | N/A |
| Industry | | Computer Software: Programming Data Processing |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.4M | 120.1M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | HURA | SANG |
|---|---|---|
| Price | $2.52 | $3.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | ★ 479.8K | 2.8K |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $3.40 |
| 52 Week High | $3.90 | $6.46 |
Technical Indicators
Market Signals| Indicator | HURA | SANG |
|---|---|---|
| Relative Strength Index (RSI) | 60.17 | 44.76 |
| Support Level | $2.38 | $3.44 |
| Resistance Level | $2.68 | $3.80 |
| Average True Range (ATR) | 0.18 | 0.13 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 99.89 | 46.51 |
Price Performance
Historical ComparisonAbout HURA TuHURA Biosciences Inc.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.